ATAP Advocates
Taking a Stand For Patients
existence (1).png

Activities

Activities

olive.PNG

                              Engaging Policymakers on Capitol Hill

ATAP representatives regularly meet with Congressional members and their staff in DC to educate them on the rebate system and the drug market and to discuss potential legislative solutions. To date, we have met with over 20 members and their staff, including Representatives Doug Collins (R-GA) and Buddy Carter (R-GA), and Senators Chuck Grassley (R-IA), Paul Ryan (R-KY), and Al Franken (D-MN). ATAP representatives have also met with representatives from the Office of Management and Budget and are working with them to develop solutions through budgetary mechanisms. We also sent a letter expressing our support for the Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act (S. 637) to Senator Ron Wyden (D-OR), and are working with his and other Senator’s offices on garner support for this bill.

ATAP representative have also had multiple meetings with MedPAC to discuss the impact of the rebate system and PBMs on Medicare, including one with MedPAC Commissioners Kathy Buto and Jack Hoadley. Currently, ATAP and MedPAC are actively working together to develop a comprehensive solution to address this problem.

olive.PNG

                       Comprehensive Media Outreach & Engagement

Providing physicians and their patients with a strong voice in the debate over drug costs and access to treatment is a top priority for ATAP. Through an effective media strategy, we are continuously engaging in outreach and working with the media to raise awareness on the rebate system and the prescription drug market.

Numerous ATAP representatives have authored or contributed to a variety of published material on PBMs and the prescription drug market, and even more articles and op-eds are in the works. We are also working diligently to identify and reach out to patients and physicians who have been forced to deal with the very real consequences the broken prescription drug system. We work with these patients and physicians to help them tell their story, and often times we are able to connect them with members of the media who want to hear the consequences for patients who need their medications to live and the physicians trying to provide them the best possible care, not the complaints of profitable corporations.

ATAP is active on social media and regularly develops and distributes content and educational materials to further raise awareness and empower patients and physicians to speak up and advocate for change.

olive.PNG

                ATAP State Advocacy & Model Legislation Working Group

This working group is currently in the process of crafting and finalizing an advanced targeted state advocacy strategy that identifies key target states in which to pursue ATAP’s two-fold initiative of education and legislative advocacy in 2018. The group is also working to develop model legislation to bring to state legislatures after laying the proper groundwork through educating state lawmakers and engaging in grassroots advocacy outreach.

olive.PNG

                           Engaging Medical Associations at Every Level

ATAP actively seeks ways to work and engage with both county and state medical associations in addition to the American Medical Association. We have had a number of successes so far, including:
                a.  Obtained a formal endorsement by the Palm Beach County Medical Society.
                b.  Developed and introduced a resolution on PBMs and the rebate system in the Florida Medical Association House of Delegates, which was passed and adopted into FMA                             policy in August.
                c.  Developed a resolution on PBMs and the rebate system that will be introduced in the American Medical Association House of Delegates at the upcoming 2017 Interim                                   Meeting.

olive.PNG

                           Active & Productive Membership Outreach

We already have a strong foundation of members in just the few months following our formation, and we are growing and expanding rapidly! We are actively recruiting both patient and provider groups from all practice areas and disease states to join us in our efforts to lower drug costs for patients and improve physician and patient access to affordable treatment.